Tuesday, 14th May 2019 | 19:00 (60 mins)


In this webinar, consideration will be given to the evidence for the targeted screening of hypogonadism amongst the male diabetic population and the role of testosterone replacement therapy as part of a holistic strategy in managing their hypogonadism.


  • Prevalence of TD and Diabetes
  • Physiology
  • Evidence base for treating TD in male diabetic patients
  • Manage of TD in Diabetic male patients



Dr Kam Mann


Men’s Health Physician with specialist interests in Sexual medicine and Andrology.
London, Winchester and Southampton, United Kingdom

Kam is an experienced Physician with a specialist interest in Men’s Health, Sexual medicine and Andrology. He completed the Multidisciplinary Joint Committee of Sexual Medicine (MJCSM) course and is a Fellow of the European Committee of Sexual Medicine (FECSM). He continues to work in the NHS Andrology unit at University Hospital Southampton and privately with The Mann Clinic with clinics in London, Winchester and Southampton.

He performs assessments on patients with testosterone deficiency, erectile dysfunction, penile rehabilitation, premature ejaculation, delayed ejaculation, cancer and sexuality problems and Men’s health and wellness.

He is treasurer of the British Society for Sexual Medicine (BSSM) and a Member of the European and International Societies of Sexual Medicine (ESSM, ISSM). He is a co-author of the Men’s Health Guidelines for General Practice.

Dr. Mann has been invited as a speaker and chaired scientific meetings in the field of Men’s health, Sexual medicine and Andrology.

Professor Hugh Jones

Professor Hugh Jones
Consultant Physician General Medicine

Diabetes and Endocrinology - Barnsley Hospital, Consultant Endocrinologist – Royal Hallamshire Hospital
Sheffield, UK

Professor Hugh Jones is a Consultant Physician in general internal medicine, diabetes and endocrinology at Barnsley Hospital. He is also an Honorary Professor of Andrology in the Department of Human Metabolism the University of Sheffield Medical School, Sheffield, UK and Hon. Consultant Endocrinologist at the Royal Hallamshire Hospital, Sheffield.

Prof. Jones is a clinical and laboratory researcher, looking into the role of testosterone in the pathogenesis and treatment of various conditions and pathologies. His major scientific discoveries are many and varied including for example determining the mechanisms of action of testosterone as an arterial vasodilator (L-channel calcium blocker).

He was elected to the European Academy of Andrology and is a co-chair of the testosterone and metabolic disorders group as part of the International Consultation on Men's Health and Infertility to be submitted to the WHO). He is a Member of the European Association of Urology Guideline committee for Male Hypogonadism and Chair of Academic sub-committee of ABCD.

View now

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk.

Adverse events should also be reported to Bayer plc, Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.

If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc, Email: qualitycomplaints@bayer.com

For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.